Science and technology engagement: Supporting public understanding of cutting-edge

  • Funded by National Research Foundation (NRF)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    National Research Foundation (NRF)
  • Principal Investigator

    Dr. Daisy Umutoni
  • Research Location

    Rwanda
  • Lead Research Institution

    HealthEdu LTD
  • Research Priority Alignment

    N/A
  • Research Category

    Policies for public health, disease control & community resilience

  • Research Subcategory

    Community engagement

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

In December 2019, an infectious outbreak in Wuhan, China led to the discovery of the pneumonia-causing, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its disease, COVID-19, that would soon be declared a pandemic by the World Health Organization (WHO). The Corona virus family is known to cause asymptomatic or mild disease in humas such as common colds, but occasionally zoonotic strains have jumped from animal reservoirs to humans causing severe disease as exemplified by SARS-CoV in 2003 and the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012. Considerable effort has been employed to fight the COVID-19 pandemic including infection prevention and control measures, candidate drugs to improve the clinical outcomes of severely ill patients and vaccine production. Despite the promising progress towards ending the pandemic, there has been an overwhelming amount of disinformation and misinformation to the public that was termed an "infodemic" by the WHO. This wrong information prevents public involvement in limiting the spread of the virus and in creating innovative solutions. To Counter the spread of unreliable COVID-19 related information, HealthEdu LTD (henceforth referred to as HeathEdu) science communicators comprised of PhD level Scientists, Clinicians, Public health and ICT experts, will identify and report on research studies that are sufficiently noteworthy based on well established measures of rigor and reproducibility, and that satisfy one of the following criteria: a) discovery of a mechanism(s) of disease causation; b) epidemiological assessment of disease prevalence; c) identification and/or assessment of a potential treatment, vaccine, medical device, or a novel diagnostic procedure; and d) innovative biomedical, technological, or epidemiological approaches that can be feasibly applied to diagnose, monitor prevalence, or directly tackle the COVID-19 pandemic. Expected Outputs  A frequently asked questions and answers section updated monthly according to cutting-edge COVID-19 knowledge and the questions of the East African public (health professionals-inclusive), will be availed by HealthEdu experts using an already existing online platform.  Through HealthEdu mass media partners, hard-to-reach communities will be engaged through radio and televised interviews with different experts that will engage these communities and answer their questions concerning COVID-19.  An online collaborative platform built by HealthEdu where scientists, medical doctors, public health and ICT experts will help to verify information that may be shared with the public by regional journalists. Using this platform, Journalists will also train the HealthEdu members on how to better engage and share their knowledge with the layman.